Semaglutide (Ozempic) raises questions about mood and nonresponse
1. Reports of emotional flattening among some users of semaglutide (Ozempic) have brought new attention to how glucagon-like peptide-1 receptor...
Public Health
Reports of high-impact public health and policy studies by medical professionals
The Scan by 2 Minute Medicine®: celebrity whole-body MRI craze floods clinics, cruise ship hantavirus outbreak prompts global tracing, “Ozempic personality” raises new questions, and TikTok’s “cortisol face” trend drives endocrine workups
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers....
Recombinant Zoster Vaccination May Reduce Dementia Risk in Older Adults
1. In this target trial emulation, receipt of the recombinant zoster vaccine (RZV) was associated with a reduced risk of...
2MM: AI Roundup: Food and Drug Administration reviews liver injury prediction tool, Joint Commission launches healthcare artificial intelligence certification, governance playbooks aim to standardize adoption, and pediatric hospitals bring generative tools to the frontline
Food and Drug Administration reviews artificial intelligence tool for liver injury prediction The Food and Drug Administration (FDA) is reviewing...
Ensitrelvir associated with reduced risk of Covid-19 among household contacts
1. In this randomized controlled trial, household contacts of patients with Covid-19 who received ensitrelvir shortly after exposure had reduced...
2MM: AI Roundup – PrescriberPoint launches autonomous agent for prior authorization, Utah begins first in nation autonomous AI prescribing pilot, and JAMA study confirms ambient AI scribes return hours to the clinician work week
PrescriberPoint artificial intelligence agent streamlines prior authorization workflow PrescriberPoint shared on April 21, 2026 that it is rolling out an...
Orforglipron (Foundayo) expands oral treatment options for weight management
1. Orforglipron (Foundayo) introduces a new oral glucagon-like peptide-1 (GLP-1) receptor agonist that can be taken without food or timing...
Housing insecurity is associated with increased risk of geriatric conditions and mortality
1. Poor housing affordability and poor housing quality were associated with the development of geriatric conditions and mortality over 5...
Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders
1. Glucagon-like peptide-1 (GLP-1) receptor agonists are associated with a lower risk of developing new substance use disorders. 2. These...
Global medicine supply chains face mounting pressure amid Strait of Hormuz disruptions
1. Shipping slowdowns in the Strait of Hormuz are disrupting the movement of key pharmaceutical ingredients and finished generic drugs....
